Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Filed Feb 14, 2017 · 10-Q · 45 days after period end · 0001640334-17-000299
| Metric | Q1 2017 | Q1 2016 |
|---|---|---|
| Net Income | -$7.41K | -$13.83K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Feb 14, 2017 · 45 d after period end
